Eagle Pharmaceuticals, Inc. Payments to Acquire Intangible Assets
Eagle Pharmaceuticals, Inc. reported Payments to Acquire Intangible Assets of $5.00 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireIntangibleAssets · last filed 2022-03-08
- Eagle Pharmaceuticals, Inc. payments to acquire intangible assets for the quarter ending 2018-12-31 was $0.00.
- Eagle Pharmaceuticals, Inc. payments to acquire intangible assets for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Eagle Pharmaceuticals, Inc. payments to acquire intangible assets for the quarter ending 2016-12-31 was $250.00K.
- Eagle Pharmaceuticals, Inc. payments to acquire intangible assets for the quarter ending 2015-12-31 was $0.00.
- Eagle Pharmaceuticals, Inc. payments to acquire intangible assets for fiscal 2021 was $5.00M.
- Eagle Pharmaceuticals, Inc. payments to acquire intangible assets for fiscal 2020 was $0.00.
- Eagle Pharmaceuticals, Inc. payments to acquire intangible assets for fiscal 2019 was $0.00.
- Eagle Pharmaceuticals, Inc. payments to acquire intangible assets for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
| Period end | Payments to Acquire Intangible Assets 3 month | Payments to Acquire Intangible Assets 9 month | Payments to Acquire Intangible Assets 12 month | Payments to Acquire Intangible Assets 12 month as first filed |
|---|---|---|---|---|
| 2021-12-31 | $5.00M 10-K · filed 2022-03-08 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-08 | $17.50M 10-K · filed 2021-03-05 | ||
| 2019-12-31 | $0.00 10-K · filed 2022-03-08 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $0.00 10-K · filed 2021-03-05 | ||
| 2018-09-30 | $0.00 10-Q · filed 2018-11-01 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $750.00K 10-K · filed 2020-03-02 | ||
| 2017-09-30 | $750.00K 10-Q · filed 2018-11-01 | |||
| 2016-12-31 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $14.25M 10-K · filed 2019-02-28 | ||
| 2016-09-30 | $14.00M 10-Q · filed 2017-11-08 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $0.00 10-K · filed 2018-02-26 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-09 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 | |||
| 2014-09-30 | $0.00 10-K · filed 2017-03-15 |